Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC‐HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel

• Váldodahkkit: John P. Savaryn (Dahkki), Richard L. Smith (Dahkki), Matthew Rosebraugh (Dahkki), Melina Neenan (Dahkki), Richard Burton (Dahkki), Kennan Marsh (Dahkki), David Wagner (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2024-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Analysis was conducted to compare levodopa/carbidopa pharmacokinetics and drug‐related material in plasma of healthy participants after receiving a continuous infusion of Levodopa/Carbidopa Intestinal Gel (LCIG) to a continuous subcutaneous infusion of foslevodopa/foscarbidopa. Study sample...